Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Fujishiro

Showing results (611-620 of 700) with videos related to

Pageof 70
Sort By:
Journal of Gastroenterology|April 16, 2026
Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01)Kazunaga Ishigaki, Yousuke Nakai, Kousuke Kashiwabara, et al.
Journal of Gastroenterology|July 28, 2023
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma casesHiroki Oyama, Tsuyoshi Hamada, Yousuke Nakai, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 5, 2021
Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional CureTakashi Honda, Norie Yamada, Asako Murayama, et al.
International Journal of Cancer|September 7, 2013
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titerTakeichi Yoshida, Jun Kato, Izumi Inoue, et al.
International Journal of Clinical Oncology|February 6, 2024
Skeletal muscle status and survival among patients with advanced biliary tract cancerShinya Takaoka, Tsuyoshi Hamada, Naminatsu Takahara, et al.
Oncogene|May 4, 2022
Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeuticsTadashi Iida, Yasuyuki Mizutani, Nobutoshi Esaki, et al.
Oncogene|April 13, 2022
Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeuticsTadashi Iida, Yasuyuki Mizutani, Nobutoshi Esaki, et al.
The Journal of Clinical Investigation|May 19, 2026
Meflin confers antifibrotic properties to intestinal fibroblasts in inflammatory bowel diseaseJingxi Mu, Keiko Maeda, Tadashi Iida, et al.
Journal of Gastroenterology|May 2, 2025
Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT databaseGo Endo, Kazunaga Ishigaki, Yousuke Nakai, et al.
Digestive Diseases (Basel, Switzerland)|January 29, 2026
Predictive Factors for Abnormal Diagnostic Colonoscopy Findings among Pediatric Patients: A retrospective cohort studyKazuki Honjo, Keita Murakami, Junya Arai, et al.
Pageof 70

Showing results (611-620 of 700) with videos related to

Sort By:
Pageof 70
Journal of Gastroenterology|April 16, 2026
Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01)Kazunaga Ishigaki, Yousuke Nakai, Kousuke Kashiwabara, et al.
Journal of Gastroenterology|July 28, 2023
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma casesHiroki Oyama, Tsuyoshi Hamada, Yousuke Nakai, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 5, 2021
Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional CureTakashi Honda, Norie Yamada, Asako Murayama, et al.
International Journal of Cancer|September 7, 2013
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titerTakeichi Yoshida, Jun Kato, Izumi Inoue, et al.
International Journal of Clinical Oncology|February 6, 2024
Skeletal muscle status and survival among patients with advanced biliary tract cancerShinya Takaoka, Tsuyoshi Hamada, Naminatsu Takahara, et al.
Oncogene|May 4, 2022
Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeuticsTadashi Iida, Yasuyuki Mizutani, Nobutoshi Esaki, et al.
Oncogene|April 13, 2022
Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeuticsTadashi Iida, Yasuyuki Mizutani, Nobutoshi Esaki, et al.
The Journal of Clinical Investigation|May 19, 2026
Meflin confers antifibrotic properties to intestinal fibroblasts in inflammatory bowel diseaseJingxi Mu, Keiko Maeda, Tadashi Iida, et al.
Journal of Gastroenterology|May 2, 2025
Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT databaseGo Endo, Kazunaga Ishigaki, Yousuke Nakai, et al.
Digestive Diseases (Basel, Switzerland)|January 29, 2026
Predictive Factors for Abnormal Diagnostic Colonoscopy Findings among Pediatric Patients: A retrospective cohort studyKazuki Honjo, Keita Murakami, Junya Arai, et al.
Pageof 70